Atlas Trials

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Clinical trial NCT07226531 · COMPLETED

Trial details

NCT number
NCT07226531
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Alopecia Areata
Start date
2025-12-22
Primary completion
2026-03-06
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.